199 related articles for article (PubMed ID: 12370825)
41. Estrogen receptor alpha and beta profiling in human breast cancer.
Balfe P; McCann A; McGoldrick A; McAllister K; Kennedy M; Dervan P; Kerin MJ
Eur J Surg Oncol; 2004 Jun; 30(5):469-74. PubMed ID: 15135471
[TBL] [Abstract][Full Text] [Related]
42. Hypermethylation of HpaII recognition sequences within the 5' coding region of the estrogen receptor gene is not associated with estrogen receptor negativity in primary breast tumours.
Kay PH; Hähnel R; Gunn H; Harmon D; Song J
Anticancer Res; 1998; 18(3A):1709-12. PubMed ID: 9673394
[TBL] [Abstract][Full Text] [Related]
43. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells.
Nass SJ; Ferguson AT; El-Ashry D; Nelson WG; Davidson NE
Oncogene; 1999 Dec; 18(52):7453-61. PubMed ID: 10602504
[TBL] [Abstract][Full Text] [Related]
44. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
45. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.
Yaich L; Dupont WD; Cavener DR; Parl FF
Cancer Res; 1992 Jan; 52(1):77-83. PubMed ID: 1345763
[TBL] [Abstract][Full Text] [Related]
47. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.
Ally MS; Al-Ghnaniem R; Pufulete M
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481
[TBL] [Abstract][Full Text] [Related]
48. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
[TBL] [Abstract][Full Text] [Related]
49. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
[TBL] [Abstract][Full Text] [Related]
50. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
Staff S; Isola J; Tanner M
Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
[TBL] [Abstract][Full Text] [Related]
51. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
[TBL] [Abstract][Full Text] [Related]
52. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Ferguson AT; Lapidus RG; Baylin SB; Davidson NE
Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900
[TBL] [Abstract][Full Text] [Related]
53. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): A rapid method to screen for and analyze methylation.
Bianco T; Hussey D; Dobrovic A
Hum Mutat; 1999; 14(4):289-93. PubMed ID: 10502775
[TBL] [Abstract][Full Text] [Related]
54. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
55. No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas.
Tokunaga E; Kimura Y; Maehara Y
Breast Cancer Res Treat; 2004 Apr; 84(3):289-92. PubMed ID: 15026626
[TBL] [Abstract][Full Text] [Related]
56. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
[TBL] [Abstract][Full Text] [Related]
57. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
58. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.
Issa JP; Zehnbauer BA; Civin CI; Collector MI; Sharkis SJ; Davidson NE; Kaufmann SH; Baylin SB
Cancer Res; 1996 Mar; 56(5):973-77. PubMed ID: 8640788
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
[TBL] [Abstract][Full Text] [Related]
60. Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
Chen Y; Lee WH; Chew HK
J Cell Physiol; 1999 Dec; 181(3):385-92. PubMed ID: 10528224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
